+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Post transplant lymphoproliferative disease in pediatric lung transplant recipients



Post transplant lymphoproliferative disease in pediatric lung transplant recipients



Journal of Heart & Lung Transplantation 17(1): 65




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032879575

Download citation: RISBibTeXText


Related references

Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring. Pediatric Transplantation 13(5): 606-610, 2009

Analysis of risk factors for post-transplant lymphoproliferative disease in pediatric lung transplant recipients with cystic fibrosis. Pediatric Research 43(4 Part 2): 131A, 1998

Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients. Pediatric Hematology and Oncology 30(6): 520-531, 2013

Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Pediatric Transplantation 8(3): 243-248, 2004

Minimal toxicity and low incidence of post transplant lymphoproliferative disease with tacrolimus-based immunosupression in pediatric transplant recipients. JPGN 31(Suppl. 2): S267, 2000

Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study. Pediatric Transplantation 21(6):, 2017

Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatric Transplantation 5(5): 359-364, 2001

Risk factors and clinical outcomes of pediatric liver transplant recipients with post-transplant lymphoproliferative disease in a multi-ethnic Asian cohort. Transplant Infectious Disease 20(1):, 2018

Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. Journal of Medical Virology 69(2): 258-266, 2003

Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus in peripheral blood lymphocytes among pediatric solid-organ transplant recipients with and without post-transplant lymphoproliferative disease. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 432, 1999

Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients. Journal of Heart and Lung Transplantation 29(6): 648-657, 2010

Adenotonsillar hypertrophy and post-transplant lymphoproliferative disorder in pediatric renal transplant recipients. Pediatric Nephrology 19(4): 471-472, 2004

Post-transplant lymphoproliferative disorder in pediatric intestinal transplant recipients: A literature review. Pediatric Transplantation 22(5): E13211, 2018

Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders. Iranian Journal of Pediatric Hematology and Oncology 3(3): 125-134, 2013

Plasmacytoma-like post-transplant lymphoproliferative disorder seen in pediatric combined liver and intestinal transplant recipients. Pediatric Blood and Cancer 60(11): E137-E139, 2013